Heterotopic bone formation after joint replacement

Current Opinion in Rheumatology

Volumn 11, Issue 2, 1999, Pages 127-131

  Nilsson, Olle S ^a   Persson, Per Erik ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; DICLOFENAC; IBUPROFEN; INDOMETACIN; KETOROLAC; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; TENOXICAM;

ARTHROPLASTY; BONE MALFORMATION; CLINICAL PROTOCOL; HUMAN; HYPEROSTOSIS; JOINT PROSTHESIS; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TREATMENT PLANNING;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHROPLASTY, REPLACEMENT, HIP; HUMANS; OSSIFICATION, HETEROTOPIC; POSTOPERATIVE COMPLICATIONS;

EID: 0032788370     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-199903000-00008     Document Type: Review

References (39)

1. 1 Puzas JE, Miller MD, Rosier RN: Pathologic bone formation. Clin Orthop 1989, 245:269-281.
2. 2 Botte MJ, Keenan MAE, Abrams RA, von Schroeder HP, Gellman H, Mooney V: Heterotopic ossification in neuromuscular disorders. Orthopaedics 1997, 20:335-341.
3. 3 Mital MA, Garber JE, Stinson JT: Ectopic bone formation in children. J Pediatr Orthop 1987, 7:83-90.
4. 4 Huggins C: Experimental osteogenesis. Proc Soc Exp Biol Med 1930, 27:349-385.
5. 5 Morrey B, Adams R, Cabanela M: Comparison of heterotopic bone after anterolateral, transtrochanteric and posterior approaches for total hip arthroplasty. Clin Orthop 1984, 188:160-167.
6. 6 Ahrengardt L, Lindgren U: Heterotopic bone. Defining the patient at risk. Clin Orthop 1993, 293:153-159.
7. 7 Jowsey J, Coventry MB, Robins PR: Heterotopic ossification: theoretical considerations, possible etiologic factors, and a clinical review of total hip arthroplasty patients exhibiting this phenomenon. In: The Proceeding of the Hip Society, St. Louis:Mosby; 1977:210-221.
8. 8 Kjaersgaard-Anderssen P, Schmidt SA: Total hip arthroplasty. Clin Orthop 1991, 263:78-86.
9. 9 Ayers DC, McCollister, Evarts C, Parkinson JR: The prevention of heterotopic ossification in high-risk patients by low-dose radiation therapy after total hip replacement. J Bone Joint Surg Am 1978, 68:1423-1430.
10. 10 Nollen JG, van Douveren FQ: Ectopic ossification in hip arthroplasty. A retrospective study of predisposing factors in 637 cases. Acta Orthop Scand 1993, 64:185-187.
11. 11 Rosendahl S, Krogh Christoffersen J, Norgaard M: Para-articular ossification following hip replacement. Acta Orthop Scand 1977, 48:400-404.
12. 12 Brooker AF, Bowerman JW, Robinson RA, Riley LH Jr: Ectopic ossification following total hip replacement: incidence and a method of classification. J Bone Joint Surg Am 1973, 55:1629-1632.
13. 13 Ritter MA, Vaughan RB: Ectopic ossification after total hip arthroplasty. Predisposing factors, frequency and effects on results. J Bone Joint Surg Am 1977, 59:345-351.
14. 14 Charnley J: The long-term results of low-friction arthroplasty of the hip performed as a primary intervention. J Bone Joint Surg Br 1972, 54:61-76.
15. 15 DeLee J, Ferrari A, Charnley J: Ectopic bone formation following low friction arthroplasty of the hip. Clin Orthop 1976, 121:53-59.
16. 16 Sodemann B, Persson P-E, Nilsson OS: Periarticular heterotopic ossification after total hip arthroplasty for primary coxarthrosis. Clin Orthop 1988, 237:150-157.
17. 17 Sodemann B, Persson P-E, Nilsson OS: Nonsteroid anti-inflammatory drugs prevent the recurrence of heterotopic bone after excision. Arch Orthop Trauma Surg 1990, 109:53-56.
18. 18 Ritter MA, Gioe TJ: The effect of indomethacin on para-articular ectopic ossification following total hip arthroplasty. Clin Orthop 1982, 167:113-117.
19. 19 Ritter MA, Sieber JN: Prophylactic indomethacin for the prevention of of heterotopic bone formation following total hip arthroplasty. Clin Orthop 1985, 196:217-225.
20. 20 Schmidt SA, Kjaersgaard-Andersen P, Pedersen NW, Kristensen SS, Pedersen P, Nielsen JB: The use of indomethacin to prevent the formation of heterotopic bone after total hip replacement. J Bone Joint Surg Am 1988, 70:834-838.
21. 21 Knelles D, Barthel T, Karrer A, Kraus U, Eulert J, Kolbl O: Prevention of heterotopic ossification after total hip replacement. J Bone Joint Surg Br 1997, 79:596-602.
22. 22 Dorn U: Indomethacin for prevention of heterotopic ossification after hip arthroplasty. A randomized comparison between 4 and 8 days of treatment. Acta Orthop Scand 1998, 69:107-110. This report shows the efficacy of prophylaxis with nonsteroidal anti-inflammatory drugs even with short treatment time.
23. 23 Persson PE, Sodemann B, Nilsson OS: Preventive effects of ibuprofen on periarticular heterotopic ossification after total hip arthroplasty. A randomized double-blind prospective study of treatment time. Acta Orthop Scand 1998, 69:111-115. A randomized and prospective study provides evidence of the efficacy of short-term treatment with nonsteroidal anti-inflammatory drugs in preventing heterotopic ossification after hip arthroplasty.
24. 24 Elmstedt E, Lindholm TS, Nilsson OS, Tornkvist H: Effect of ibuprofen on heterotopic ossification after hip replacement. Acta Orthop Scand 1985, 56:25-27.
25. 25 Gebuhr P, Sletgard J, Dalsgard J, Soelberg M, Keisu K, Hanninen A, Crawford M: Heterotopic ossification after hip arthroplasty. A randomized double-blind multicenter study of tenoxicam in 147 hips. Acta Orthop Scand 1996, 67:29-32.
26. 26 Pritchett JW: Ketorolac prophylaxis against heterotopic ossification after hip replacement. Clin Orthop 1995, 314:162-165.
27. 27 Wahlstrom O, Risto O, Djerf K, Hammerby S: Heterotopic bone formation prevented by diclofenac. Prospective study of 100 hip arthroplasties. Acta Orthop Scand 1991; 62:419-521.
28. 28 Wurnig C, Auersperg V, Boehler N, Steindl M, Kiss H, Zweymuller K, Kotz R: Short-term prophylaxis against heterotopic bone after cementless hip replacement. Clin Orthop 1997, 334:175-183.
29. 29 Kjaersgaard-Anderssen P, Schmidt SA: Indomethacin for prevention of ectopic ossification after hip arthroplasty. Acta Orthop Scand 1986, 57:12-14.
30. 30 Sodemann B, Persson P-E, Nilsson OS: Prevention of periarticular heterotopic ossification following total hip arthroplasty. Clinical experience with indomethacin and ibuprofen. Arch Orthop Trauma Surg 1988, 107:329-333.
31. 31 Keller JC, Trancik TM, Young FA, St. Mary E: Effects of indomethacin on bone ingrowth. J Orthop Res 1989, 7:28-32.
32. 32 Kjaersgaard-Andersen P, Schmidt SA, Pedersen NW, Kristensen SS, Pedersen P: Early radiolucencies following cemented total hip replacement. Orthopaedics 1989, 12:401-406.
33. 33 Coventry MB, Scanlon PW: The use of radiation to discourage ectopic bone. J Bone Joint Surg Am 1981, 63:201-208.
34. 34 Fingeroth RJ, Ahmed AQ: Single-dose 6 Gy prophylaxis for heterotopic ossification after total hip arthroplasty. Clin Orthop 1995, 317:131-140.
35. 35 Pellegrini VD, Gregortich SJ: Preoperative radiation for prevention of heterotopic ossification following total hip arthroplasty. J Bone Joint Surg Am 1996, 78:870-881. This report shows the efficacy of preoperative radiation in preventing heterotopic ossification after hip arthroplasty.
36. 36 Leeuwen WM, Deckers P, de Lange WJ: Preoperative irradiation for prophylaxis of ectopic ossification after hip arthroplasty. Acta Orthop Scand 1988, 69:116-118. This report verifies the efficacy of preoperative radiation in preventing heterotopic ossification after hip arthroplasty.
37. 37 Sumner DR, Turner TM, Pierson RH, Kienapfel H, Urban RM, Liebner EJ, Galante JO: Effects of radiation on fixation of noncemented porous-coated implants in a canine model. J Bone Joint Surg Am 1990, 72:1527-1533.
38. 38 Rader CP, Barthel T, Haase M, Scheidler M, Eulert J: Heterotopic ossification after total knee arthroplasty. 54/615 cases after 1-6 yers follow-up. Acta Orthop Scand 1997, 68:46-50. This report is one of the very few studies on heterotopic ossification after knee arthroplasty.
39. 39 Kjaersgaard-Anderssen P, Sjoberg JO, Sneppen O: Heterotopic bone formation after arthroplasty of the shoulder, elbow and knee. Semin Arthroplasty 1992, 200-205.